| Sign In to gain access to subscriptions and/or personal tools. |
Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailabilityDivision of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Division of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Division of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Natural Products Chemistry, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Division of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Division of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Natural Products Chemistry, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Natural Products Chemistry, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, India
Division of Pharmacology, Indian Institute of Integrative Medicine (CSIR), (Formerly Regional Research Laboratory), Jammu-Tawi, IndiaJohri.rk{at}gmail.com This study deals with the pharmacokinetic interaction of selected anti-TB drugs with a natural product (CC-1a) derived from caraway (Carum carvi, L.) seed. CC-1a, chemically standardized butanolic fraction, enhanced the plasma levels of rifampicin, pyrazinamide, and isoniazid in Wistar rat, resulting in increased bioavailability indices (Cmax and AUC) of the drugs. Moreover, a 40% reduced dose regimen of these drugs, which additionally contained CC-1a, was equivalent in terms of Cmax and AUC to a normal dose regimen. A permeation-enhancing property of CC-1a across small intestinal absorptive surface was found to be a contributing factor in its bioavailability enhancing profile.
Key Words: caraway Carum carvi bioavailability enhancement isoniazid permeation pyrazinamide rifampicin
Human & Experimental Toxicology, Vol. 28, No. 4,
175-184 (2009) |
||||